Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Substance P is a neuropeptide that nerve endings release to signal pain, and when levels stay elevated, it sensitizes spinal cord neurons so mild touch or normal movement can feel sharp, burning, or electric. This amplification, driven by NK-1 receptor activation and inflammatory feedback loops, plays a role in conditions such as neuropathy, fibromyalgia, migraine, and chronic back pain. Several factors influence how much Substance P your body releases and how strongly it responds, including stress, sleep, nerve injury, and coexisting inflammation, so see below to understand the details that matter for your situation. Because amplified nerve pain can look similar across very different causes, guessing at the reason often delays the treatment that would actually help.
Taking a free, instant, online symptom check is a fast way to organize what you are feeling, see which conditions may explain it, and know which type of doctor to talk to next.
Last reviewed for medical accuracy: 08/18/2026
Chronic nerve pain can feel overwhelming, but understanding the molecular players—like Substance P—helps demystify what’s happening in your body. Substance P is a small protein (neuropeptide) that carries pain messages from your nerves to your brain. When levels of Substance P rise—especially in cerebrospinal fluid (CSF)—pain signals are amplified, leading to heightened sensitivity and persistent discomfort.
Under normal circumstances, Substance P helps you respond to injury—think pulling your hand away from a hot surface. But when its levels climb abnormally, that protective signal turns into a source of ongoing pain.
Cerebrospinal fluid cushions the brain and spinal cord. Measuring Substance P levels in CSF gives clinicians a window into central nervous system activity. Research shows:
These findings highlight Substance P as both a marker and mediator of chronic pain conditions.
Central Sensitization
• Repeated release of Substance P in the spinal cord “primes” pain pathways.
• Neurons become hyper-responsive—a phenomenon called “wind-up.”
• Even mild stimuli (e.g., light touch) can trigger severe pain.
Neurogenic Inflammation
• Substance P promotes the release of inflammatory molecules (histamine, prostaglandins).
• Blood vessels become more permeable, leading to redness, swelling, and tenderness.
Cross-Talk Between Nerves
• Substance P can spill over to neighboring nerve fibers, spreading pain beyond the original site.
• This contributes to the sensation of pain radiating or “shooting” along a limb.
Together, these processes create a feedback loop: more pain leads to more Substance P release, which then fuels further sensitization.
Understanding Substance P dynamics guides both diagnosis and treatment:
Diagnostics
• CSF sampling via lumbar puncture can quantify Substance P.
• Elevated levels support diagnoses of fibromyalgia and certain neuropathic syndromes.
• Combined with patient history and clinical exam, CSF analysis refines treatment plans.
Prognosis
• Higher Substance P levels often predict poorer response to standard analgesics.
• Monitoring CSF levels can help track disease progression or treatment effectiveness.
While directly blocking Substance P has proven challenging, several approaches help dial down its effects:
NK1 Receptor Antagonists
• Designed to prevent Substance P from binding to NK1 receptors.
• Some show promise in reducing central sensitization; research is ongoing.
Capsaicin Preparations
• High-potency topical creams deplete Substance P from nerve endings.
• Initial application may sting, but repeated use leads to pain relief over weeks.
Antidepressants (e.g., SNRIs, TCAs)
• Increase levels of serotonin and norepinephrine, which inhibit pain pathways.
• May indirectly reduce Substance P release in the spinal cord.
Gabapentinoids (Gabapentin, Pregabalin)
• Modulate calcium channels on nerve endings.
• Lower excessive neurotransmitter release, including Substance P.
Physical Therapy & Graded Exercise
• Gentle, progressive movement improves nerve function and reduces sensitization.
Cognitive Behavioral Therapy (CBT)
• Teaches coping strategies to interrupt pain-anxiety cycles that boost Substance P release.
Mind-Body Techniques
• Meditation, mindfulness, and biofeedback can lower stress-related neurotransmitter surges.
Nutritional Approaches
• Omega-3 fatty acids and antioxidants may help tamp down neurogenic inflammation.
Persistent or worsening nerve pain deserves medical attention, especially if you experience:
If you’re unsure what’s driving your pain, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help clarify your next steps.
Research into Substance P continues to uncover targeted ways to disrupt its role in chronic pain. Clinical trials of novel NK1 antagonists, combined therapies, and personalized medicine approaches offer hope for more effective relief.
In the meantime, a multi-modal plan—combining medication, therapy, lifestyle changes, and close collaboration with your healthcare team—remains the cornerstone of managing pain amplified by Substance P.
Always speak to a doctor about any pain or symptoms that are severe, worsening, or affecting your daily life. Early intervention and tailored treatment can make all the difference.
(References)
* Bernstein JE. Capsaicin and substance P. Clin Dermatol. 1991 Oct-Dec;9(4):497-503. doi: 10.1016/0738-081x(91)90078-y. PMID: 1726584.
* Clohisy DR, Mantyh PW. Bone cancer pain. Cancer. 2003 Feb 1;97(3 Suppl):866-73. doi: 10.1002/cncr.11144. PMID: 12548588.
* Zieglgänsberger W, Berthele A, Tölle TR. Understanding neuropathic pain. CNS Spectr. 2005 Apr;10(4):298-308. doi: 10.1017/s1092852900022628. PMID: 15788957.
* Gurnani B, Feroze KB, Patel BC. Neurotrophic Keratitis. 2026 Jan. PMID: 28613758.
* Kuruvilla M, Kalangara J, Lee FEE. Neuropathic Pain and Itch Mechanisms Underlying Allergic Conjunctivitis. J Investig Allergol Clin Immunol. 2019;29(5):349-356. doi: 10.18176/jiaci.0320. Epub 2018 Sep 17. PMID: 30222114.
* Green DP, Limjunyawong N, Gour N, Pundir P, Dong X. A Mast-Cell-Specific Receptor Mediates Neurogenic Inflammation and Pain. Neuron. 2019 Feb 6;101(3):412-420.e3. doi: 10.1016/j.neuron.2019.01.012. Epub 2019 Jan 24. PMID: 30686732; PMCID: PMC6462816.
* Chen SH, Lin YW, Tseng WL, Lin WT, Lin SC, Hsueh YY. Ultrahigh frequency transcutaneous electrical nerve stimulation for neuropathic pain alleviation and neuromodulation. Neurotherapeutics. 2024 Apr;21(3):e00336. doi: 10.1016/j.neurot.2024.e00336. Epub 2024 Feb 16. PMID: 38368171; PMCID: PMC10943071.
* Bagues A, Hu J, Alshanqiti I, Chung MK. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain. Pharmacol Ther. 2024 Jul;259:108668. doi: 10.1016/j.pharmthera.2024.108668. Epub 2024 May 22. PMID: 38782121; PMCID: PMC11182613.
* Farham F, Onan D, Martelletti P. Non-Migraine Head Pain and Botulinum Toxin. Toxins (Basel). 2024 Oct 9;16(10). doi: 10.3390/toxins16100431. Epub 2024 Oct 9. PMID: 39453207; PMCID: PMC11511419.
* MacDonald DI, Jayabalan M, Seaman JT, Balaji R, Nickolls AR, Chesler AT. Pain persists in mice lacking both Substance P and CGRPα signaling. Elife. 2025 Mar 18;13. doi: 10.7554/eLife.93754. Epub 2025 Mar 18. PMID: 40100256; PMCID: PMC11919252.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.